Cytogenetic Study of Ocular Melanoma

Completed

Conditions studied: Choroidal Melanoma

In brief

Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for genetic features. These features and features of subjects' clinical course are recorded. Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis.

Key facts

Study ID

NCT00344799

Run by

Jonsson Comprehensive Cancer Center

People needed

95

Starts

2005-01-08

Expected to finish

2020-10-23

Last updated by the study team

2021-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with diagnosis of ocular melanoma
• Patient with local treatment plan for ocular melanoma- plaque brachytherapy or enucleation
• Patient 18 years of age or older
• Archival enucleation specimens with diagnosis of ocular melanoma

You may not qualify if…

• Patient who refuses local melanoma treatment
• Patient who refuses to participate in this study

Where it is running

• Jules Stein Eye Institute — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.